Figures & data
Figure 1. Chemical structures of 1,2,3-triazole and 1,2,4-triazole motifs.
Figure 2. Some of the drugs available in the market containing 1,2,3-triazole ring.
Figure 3. The chemical structures of anti-lung cancer compounds 1–5.
Figure 4. The chemical structures of anti-breast cancer compounds 6–11.
Figure 5. The chemical structures of anti-gastric cancer compounds 12–13.
Figure 6. The chemical structures of anti-ovarian cancer compound 14, anti-liver cancer compounds 15–16, and anti-pancreatic cancer compound 17.
Figure 7. The chemical structures of anti-colon cancer compounds 18–20.
Figure 8. The chemical structures of anti-leukaemia compounds 21–23.
Figure 9. The chemical structures of anti-multiple cancer cells compounds 24–43.
Figure 10. The chemical structures of anti-inflammatory compounds 44–49.
Figure 11. The chemical structures of antibacterial compounds 50–58.
Figure 12. The chemical structures of antifungal compounds 59–60.
Figure 13. The chemical structures of anti-multiple timicrobial compounds 61–62.
Figure 14. The chemical structures of anti-leishmanial compounds 63–65.
Figure 15. The chemical structures of antimalarial compounds 66–71.
Figure 16. The chemical structures of anti-Toxoplasma gondii compounds 72–74.
Figure 17. The chemical structure of anti-Trypanosoma cruzi compound 75.
Figure 18. The chemical structures of anti-multiple parasitic compounds 76–77.
Figure 19. The chemical structures of antiviral compounds 78–79.
Figure 20. The chemical structures of antioxidant compounds 80–81.
Figure 21. The chemical structures of anti-Alzheimer compounds 82–91.
Figure 22. The chemical structures of enzyme inhibitors 92–94.
